Chimeric antigen receptor T-cell immunotherapy tackles blood cancers.

V. Brower

DOI: https://doi.org/10.1093/jnci/djv112

2015-04-01

Journal of the National Cancer Institute

Abstract:intervention studies, assess change, and establish relationships with theoretically relevant factors and clinically important outcomes such as mortality. " The instrument has a broad content coverage, [has] very high reliability, and is strongly linked to self-confidence about engaging in health decisions, " Dumenci said. Completing CHLT-30 takes 10–15 minutes , and the score reflects the number of correct responses. Patients in the doctor's waiting room can complete CHLT-6 in just a few minutes. Seeing these results in advance allows the doctor to prepare to speak to patients in understandable language. Dumenci said CHLT-6 has invariant measurement properties between sex and race/ethnic groups and is externally validated. These features make CHLT-6 attractive for adoption in various cancer treatment settings—particularly oncology clinics and pharmacies. The study found that 18% of cancer patients have limited CHL, especially black, undereducated, and low-income patients. " Overall, the results supported the conclusion that the CHLT-30 accurately measures CHL along a continuum, " Dumenci said, " and that the CHLT-6 efficiently identifies patients with limited CHL with high accuracy. " " It is a very robust, psychometric study, " Ganz said. " I think is very important that they studied a large sample of patients representing different races to arrive at their conclusions. " " I find the methods they used in the study are very sound, " said Wen-health literacy as not just simple knowledge but also ability, skills, and other related traits. The more knowledge the clinician has about the patients, the better the patients will understand what they're told—which can only help them navigate the cancer world. " According to Ganz, CHL is not just a problem of the poor and uneducated. Many wealthier and more educated patients also have trouble understanding and dealing with the sophisticated information cancer patients receive, especially when they're highly emotional and stressed. " One of the biggest challenges we face is appearing paternalistic, and finding the right balance of information to provide each patient is difficult. This type of screening tool could help us. " Ganz said she sees the six-question test as having more value. " I think the six items would let us know if the patient has low literacy and whether I have to work harder to make sure they understand what I'm talking about, and as a prerequisite for engaging them in informed decision making. " Chou also said she thinks CHLT-6 is more …